Opendata, web and dolomites

MammoWave

The first ultra-high sensitive breast imaging device based on non-ionizing safe microwave

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 MammoWave project word cloud

Explore the words cloud of the MammoWave project. It provides you a very rough idea of what is the project "MammoWave" about.

reflected    specificity    trials    exposed    replying    imaging    females    scanner    private    cure    limiting    microwave    innovative    illness    negative    diagnosis    marketing    azimuth    signal    cancer    algorithm    harmful    clinics    transmit    departments    positive    safe    doctors    moved    reduce    electromagnetic    strategy    rate    receiving    screening    commercialization    false    hold    paramount    reconstruction    suspected    age    patients    model    chain    business    position    mammowave    configured    defer    directions    planning    detection    outcome    complete    hospital    completely    time    distress    women    measured    plan    fast    first    antenna    cup    signals    industrialization    techniques    huygens    regular    market    device    accurate    image    clinical    receive    wave    unnecessary    hospitals    performing    establishing    elaboration    prone    sound    ionizing    supply    incidence    consist    mammography    battle    patient    breast    tissue    healthcare    pregnancy    antennas    additional    radiation    capture    tumor    implies   

Project "MammoWave" data sheet

The following table provides information about the project.

Coordinator
UMBRIA BIOENGINEERING TECNOLOGIES SOCIETA A RESPONSABILITA LIMITATA 

Organization address
address: VIA SANTA MARIA DELLA SPINA 25
city: FRAZIONE RIVOTORTO
postcode: 6081
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Project website http://www.ubt-tech.com/en/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2017
 Duration (year-month-day) from 2017-08-01   to  2017-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UMBRIA BIOENGINEERING TECNOLOGIES SOCIETA A RESPONSABILITA LIMITATA IT (FRAZIONE RIVOTORTO) coordinator 50˙000.00

Map

 Project objective

Breast cancer is the most common cancer in females. Regular screening is of paramount important for early diagnosis to reduce the incidence and increase the outcome of a cure. Current techniques based on ionizing radiation cannot be used in many cases. MammoWave is a mammography device based on safe microwave that enable a fast and accurate breast imaging allowing for an early detection of breast cancer, based on simple technology and low cost. MammoWave can be used any time, at any age and in any condition (pregnancy, specific illness etc.) for all patients since it does not use ionizing radiation. Defer to traditional mammography only cases positive for a first screening MammoWave, limiting the use of harmful radiation. The breast scanner consist of a cup that hold the breast of the patient in a prone position and of two antennas, one to transmit the microwave signal and one to receive. The breast is exposed to completely safe wave field. Both antennas are configured to be moved around the azimuth, to capture reflected electromagnetic field in all directions and measured by the receiving antenna. MammoWave is based on an innovative image reconstruction algorithm that processes the microwave signals according to the Huygens' principle: the result is able to identify the presence of any suspected tumor in the breast tissue. MammoWave addresses the market of hospitals, clinics and private doctors replying to their need of enhancing the specificity of mammography screening in breast cancer detection to battle the increasing rate of false-positive and false-negative results, which implies additional cost for the healthcare system and unnecessary distress for women. The Phase 1 project will be focused on establishing a complete supply chain, a sound business model and commercialization strategy, a planning of all activities for performing the clinical trials in hospital departments, as well as the elaboration of an industrialization and marketing plan

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MAMMOWAVE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MAMMOWAVE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.1.;H2020-EU.2.3.1.)

Starcounter (2017)

In-Memory Computing and Artificial Intelligence Platform for Building Next Generation Enterprise Software

Read More  

Meshporto_smeIns1_2 (2018)

PsstMenu allows customers to place orders directly from home or restaurant tables using only a smartphone.

Read More  

oWBI (2018)

Osmotic Wearable Bolus Injector (oWBI) for viscous drug delivery

Read More